Evidence map›Paper›PMID 30237292›Full record

ArticleBiology open2018

DARPins recognizing mTFP1 as novel reagents for

M Alessandra Vigano, Dimitri Bieli, Jonas V Schaefer, Roman P Jakob, Shinya Matsuda, Timm Maier, Andreas Plückthun, Markus Affolter

Erratum issuedAbstract read
In one paragraph

Article in Biology open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Reflections on the use of protein binders to study protein function in developmental biology.Wiley interdisciplinary reviews. Developmental biology · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

M Alessandra ViganoGrowth and Development, Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland.ORCID 0000-0003-2009-0384
Dimitri BieliGrowth and Development, Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland.
Jonas V SchaeferDepartment of Biochemistry, University of Zurich, Winterthurerstr. 190, CH-8057 Zurich, Switzerland.
Roman P JakobStructural Biology and Biophysics, Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland.ORCID 0000-0002-6451-8656
Shinya MatsudaGrowth and Development, Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland.
Timm MaierStructural Biology and Biophysics, Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland.ORCID 0000-0002-7459-1363
Andreas PlückthunDepartment of Biochemistry, University of Zurich, Winterthurerstr. 190, CH-8057 Zurich, Switzerland markus.affolter@unibas.ch plueckthun@bioc.uzh.ch.ORCID 0000-0003-4191-5306
Markus AffolterGrowth and Development, Biozentrum, University of Basel, Klingelbergstrasse 70, CH-4056 Basel, Switzerland markus.affolter@unibas.ch plueckthun@bioc.uzh.ch.ORCID 0000-0002-5171-0016

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the last few years, protein-based affinity reagents have proven very helpful in cell and developmental biology. While many of these versatile small proteins can be expressed both in the intracellular and extracellular milieu in cultured cells and in living organisms, they can also be functionalized by fusing them to different protein domains in order to regulate or modulate their target proteins in diverse manners. For example, protein binders have been employed to degrade, trap, localize or enzymatically modify specific target proteins. Whereas binders to many endogenous proteins or small protein tags have been generated, several affinity reagents against fluorescent proteins have also been created and used to manipulate target proteins tagged with the corresponding fluorescent protein. Both of these approaches have resulted in improved methods for cell biological and developmental studies. While binders against GFP and mCherry have been previously isolated and validated, we now report the generation and utilization of designed ankyrin repeat proteins (DARPins) against the monomeric teal fluorescent protein 1 (mTFP1). Here we use the generated DARPins to delocalize Rab proteins to the nuclear compartment, in which they cannot fulfil their regular functions anymore. In the future, such manipulations might enable the production of acute loss-of-function phenotypes in different cell types or in living organisms based on direct protein manipulation rather than on genetic loss-of-function analyses.

Indexed as

Crystal structureDARPinsmTFP1Protein binderRelocalization

Identifiers

PMID30237292
PMCPMC6262872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.